Health security is no longer a health question.

It is decided in trade policy, industrial strategy and foreign affairs. I speak about what that shift means for the people who have to act on it.

1. 01
   Keynote

   The molecule and the map

   Why a country that cannot make its own active ingredients does not have an independent health policy, and what rebuilding that capability actually costs. Uses the 2020 export restrictions as the opening case.

2. 02
   Keynote

   Who owns the genome of a nation

   Population genomics has turned health data into a strategic asset. Who holds it, who can analyse it, and what happens to states that hand both to someone else.

3. 03
   Panel

   Europe, the Gulf and the speed of institutions

   Europe built the pharmaceutical industry and is debating resilience in committee rooms. The Gulf started from nothing and is moving faster. What each is getting right, and what neither is admitting.

4. 04
   Closed briefing

   Health sovereignty for boards

   A working session for executive teams and investment committees: where dependency sits in your own value chain, which parts are politically exposed, and what can realistically be changed.

Keynote

30 to 45 minutes, with discussion

Moderated panel

As chair or participant

Fireside conversation

On stage or recorded

Closed-door briefing

Board or ministerial level, under Chatham House rule

Delivered in English. Based in Abu Dhabi, travelling regularly.